Sven Flemming1, Natalie Burkard1, Melanie Renschler1, Franziska Vielmuth2, Michael Meir1, Martin Alexander Schick3, Christian Wunder3, Christoph-Thomas Germer1, Volker Spindler2, Jens Waschke2, Nicolas Schlegel4. 1. Department of General, Visceral, Vascular and Paediatric Surgery (Department of Surgery I), University of Wuerzburg, Oberduerrbacherstraße 6, Wuerzburg D-97080, Germany. 2. Institute of Anatomy and Cell Biology, University of Munich, Munich D-80336, Germany. 3. Department of Anaesthesia and Critical Care, University of Wuerzburg, Wuerzburg D-97080, Germany. 4. Department of General, Visceral, Vascular and Paediatric Surgery (Department of Surgery I), University of Wuerzburg, Oberduerrbacherstraße 6, Wuerzburg D-97080, Germany Schlegel_N@ukw.de.
Abstract
AIMS: Microvascular endothelial barrier breakdown in sepsis precedes organ failure and death in patients. We tested the hypothesis that the formation of endothelium-derived soluble vascular endothelial (VE)-cadherin fragments (sVE-cadherin) is involved in inflammation-induced endothelial barrier disruption. METHODS AND RESULTS: Incubation of human dermal microvascular endothelial cells (HDMEC) with tumour necrosis factor-α (TNF-α) and bacterial lipopolysaccharide (LPS) led to endothelial barrier disruption which correlated with significantly increased sVE-cadherin at a size of ∼90 kDa in cell culture supernatants. Inhibition of the VE-cadherin-cleaving disintegrin and metalloproteinase ADAM10 using GI254023X attenuated inflammation-induced formation of sVE-cadherin and endothelial barrier disruption, suggesting ADAM10-mediated shedding as a mechanism underlying sVE-cadherin release. Formation of VE-cadherin fragments at 90 and 110 kDa was observed when recombinant VE-cadherin (rVE-cadherin) was digested with recombinant ADAM10. Mass spectrometry of the VE-cadherin fragments showed that they originated from cleavage of the extracelluar domain and thereby several cleavage sites of ADAM10 were identified. Atomic force microscopy measurements demonstrated that cell culture supernatants containing sVE-cadherin and application of rVE-cadherin blocked VE-cadherin binding. Accordingly rVE-cadherin dose-dependently led to loss of endothelial barrier functions in HDMEC monolayers. Finally, in patients suffering from severe sepsis or septic shock with clinical signs of a microvascular leackage, serum levels of sVE-cadherin were significantly increased. CONCLUSION: Taken together, formation of sVE-cadherin is associated and contributes to inflammation-induced breakdown of endothelial barrier functions by inhibition of VE-cadherin binding. The underlying mechanism of VE-cadherin cleavage involves ADAM10 and appears to be of clinical relevance since sVE-cadherin was augmented in patients with severe sepsis. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: Microvascular endothelial barrier breakdown in sepsis precedes organ failure and death in patients. We tested the hypothesis that the formation of endothelium-derived soluble vascular endothelial (VE)-cadherin fragments (sVE-cadherin) is involved in inflammation-induced endothelial barrier disruption. METHODS AND RESULTS: Incubation of human dermal microvascular endothelial cells (HDMEC) with tumour necrosis factor-α (TNF-α) and bacterial lipopolysaccharide (LPS) led to endothelial barrier disruption which correlated with significantly increased sVE-cadherin at a size of ∼90 kDa in cell culture supernatants. Inhibition of the VE-cadherin-cleaving disintegrin and metalloproteinase ADAM10 using GI254023X attenuated inflammation-induced formation of sVE-cadherin and endothelial barrier disruption, suggesting ADAM10-mediated shedding as a mechanism underlying sVE-cadherin release. Formation of VE-cadherin fragments at 90 and 110 kDa was observed when recombinant VE-cadherin (rVE-cadherin) was digested with recombinant ADAM10. Mass spectrometry of the VE-cadherin fragments showed that they originated from cleavage of the extracelluar domain and thereby several cleavage sites of ADAM10 were identified. Atomic force microscopy measurements demonstrated that cell culture supernatants containing sVE-cadherin and application of rVE-cadherin blocked VE-cadherin binding. Accordingly rVE-cadherin dose-dependently led to loss of endothelial barrier functions in HDMEC monolayers. Finally, in patients suffering from severe sepsis or septic shock with clinical signs of a microvascular leackage, serum levels of sVE-cadherin were significantly increased. CONCLUSION: Taken together, formation of sVE-cadherin is associated and contributes to inflammation-induced breakdown of endothelial barrier functions by inhibition of VE-cadherin binding. The underlying mechanism of VE-cadherin cleavage involves ADAM10 and appears to be of clinical relevance since sVE-cadherin was augmented in patients with severe sepsis. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Victoria Langer; Eugenia Vivi; Daniela Regensburger; Thomas H Winkler; Maximilian J Waldner; Timo Rath; Benjamin Schmid; Lisa Skottke; Somin Lee; Noo Li Jeon; Thomas Wohlfahrt; Viktoria Kramer; Philipp Tripal; Michael Schumann; Stephan Kersting; Claudia Handtrack; Carol I Geppert; Karina Suchowski; Ralf H Adams; Christoph Becker; Andreas Ramming; Elisabeth Naschberger; Nathalie Britzen-Laurent; Michael Stürzl Journal: J Clin Invest Date: 2019-11-01 Impact factor: 14.808
Authors: Michael Meir; Natalie Burkard; Hanna Ungewiß; Markus Diefenbacher; Sven Flemming; Felix Kannapin; Christoph-Thomas Germer; Matthias Schweinlin; Marco Metzger; Jens Waschke; Nicolas Schlegel Journal: J Clin Invest Date: 2019-06-17 Impact factor: 14.808
Authors: S Lefere; F Van de Velde; L Devisscher; M Bekaert; S Raevens; X Verhelst; Y Van Nieuwenhove; M Praet; A Hoorens; C Van Steenkiste; H Van Vlierberghe; B Lapauw; A Geerts Journal: Int J Obes (Lond) Date: 2017-05-02 Impact factor: 5.095
Authors: Robert Szulcek; Chris M Happé; Nina Rol; Ruud D Fontijn; Chris Dickhoff; Koen J Hartemink; Katrien Grünberg; Ly Tu; Wim Timens; George D Nossent; Marinus A Paul; Thomas A Leyen; Anton J Horrevoets; Frances S de Man; Christophe Guignabert; Paul B Yu; Anton Vonk-Noordegraaf; Geerten P van Nieuw Amerongen; Harm J Bogaard Journal: Am J Respir Crit Care Med Date: 2016-06-15 Impact factor: 21.405
Authors: Hajime Takase; Sherry Hsiang-Yi Chou; Gen Hamanaka; Ryo Ohtomo; Mohammad R Islam; Jong Woo Lee; Liangge Hsu; Justin Mathew; Estefania Reyes-Bricio; Kazuhide Hayakawa; Changhong Xing; Ming Ming Ning; Xiaoying Wang; Ken Arai; Eng H Lo; Josephine Lok Journal: Neurology Date: 2020-02-27 Impact factor: 9.910